1. Home
  2. SCI vs RGEN Comparison

SCI vs RGEN Comparison

Compare SCI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Service Corporation International

SCI

Service Corporation International

N/A

Current Price

$71.88

Market Cap

10.2B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$171.33

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCI
RGEN
Founded
1962
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
11.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
SCI
RGEN
Price
$71.88
$171.33
Analyst Decision
Strong Buy
Buy
Analyst Count
7
20
Target Price
$92.29
★ $203.21
AVG Volume (30 Days)
★ 1.5M
1.1M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
★ 1.96%
N/A
EPS Growth
7.65
★ 286.96
EPS
★ 2.90
N/A
Revenue
★ $4,309,234,000.00
$141,236,000.00
Revenue This Year
$3.44
$14.98
Revenue Next Year
$3.67
$26.05
P/E Ratio
$25.33
★ N/A
Revenue Growth
2.93
★ 35.10
52 Week Low
$68.41
$100.99
52 Week High
$90.99
$198.87

Technical Indicators

Market Signals
Indicator
SCI
RGEN
Relative Strength Index (RSI) 36.44 47.16
Support Level $72.16 $161.15
Resistance Level $84.99 $188.59
Average True Range (ATR) 2.20 7.31
MACD -0.32 -1.15
Stochastic Oscillator 6.60 34.91

Price Performance

Historical Comparison
SCI
RGEN

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, it provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. The company derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: